Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-04-04

FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approves a supplemental application for carvedilol from Aurobindo Pharma Limited, enabling continued market supply of this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CARVEDILOL (Carvedilol)

Snippet

SUPPL AP for CARVEDILOL (CARVEDILOL)